Apr 16 |
Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalysts
|
Apr 9 |
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Mar 17 |
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns
|
Mar 7 |
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know
|
Mar 5 |
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
|
Feb 29 |
Lyell Immunopharma files $400M mixed securities shelf
|
Feb 28 |
Lyell Immunopharma reports Q4 results
|
Feb 28 |
Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights
|
Feb 28 |
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
|
Feb 26 |
Lyell Immunopharma Announces Participation in March Investor Conferences
|